Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

Gastrointestinal Hormones Clinical Trial

Official title:
Impact of Two Genetic Variants of OATP 1B3 or MRP 2 or Rifampin Mediated Transporter Inhibition on Systemic Disposition and Biological Efficacy of CCK-8 in 36 Healthy Male Individuals

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the impact of genetic variants of OATP 1B3 or MRP 2 on the systemic disposition of endogenously formed CCK-8 and to determine the influence of a single-dose of the transporter inhibitor rifampin (600 mg) on the systemic disposition of endogenously formed CCK-8. Endogenous CCK-8 secretion will be induced by a single-dose standardized liquid mixed meal.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Gastrointestinal Hormones

Clinical Trial Details

NCT number	NCT02507167
Study type	Interventional
Source	University Medicine Greifswald
Contact
Status	Completed
Phase	Phase 1
Start date	November 2012
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06022315` - Impact of Macronutrient Composition of Energy-restricted Diet and Exercise on Body Composition and Appetite Hormones.	N/A
Completed	`NCT05279183` - Assessment of Reward Responses to Erythritol Using Flavor Preference Learning	N/A
Active, not recruiting	`NCT05671965` - Effects of Oral Xylitol on Subsequent Energy Intake	N/A
Completed	`NCT04713137` - Effects of Oral Pre-loads on Subsequent Energy Intake	N/A
Completed	`NCT00468091` - Effects of Exendin(9-39) on Gastroduodenal Motility	Phase 1
Completed	`NCT04249609` - Composition of Meals Around Exercise Session	N/A
Not yet recruiting	`NCT05302206` - Colonic Glucose vs. Saline Infusion	N/A